<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Observational Study Demonstrates No Greater Incidence of Progression to Acute Myeloid Leukemia with REVLIMID® in Patients with Lower-Risk Del(5q) Myelodysplastic Syndromes</title>
	<atom:link href="http://symptomadvice.com/observational-study-demonstrates-no-greater-incidence-of-progression-to-acute-myeloid-leukemia-with-revlimid%c2%ae-in-patients-with-lower-risk-del5q-myelodysplastic-syndromes/feed/" rel="self" type="application/rss+xml" />
	<link>http://symptomadvice.com/observational-study-demonstrates-no-greater-incidence-of-progression-to-acute-myeloid-leukemia-with-revlimid%c2%ae-in-patients-with-lower-risk-del5q-myelodysplastic-syndromes/</link>
	<description></description>
	<lastBuildDate>Thu, 11 Nov 2010 05:59:24 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
</channel>
</rss>
